Table 3.
Vimentin expression and clinicopathological parameters of breast carcinoma in triple-negative breast carcinoma cases
| Variables (n) | Vimentin expression |
P | |
|---|---|---|---|
| Positive (%) 18 (94.7) | Negative (%) 1 (5.3) | ||
| Age (years) | |||
| ≤50 (8) | 7 (36.8) | 1 (5.3) | 0.870 |
| >50 (11) | 11 (57.9) | 0 | |
| Menopausal status (n=19) | |||
| Premenopausal (3) | 2 (10.5) | 1 (5.3) | 0.335 |
| Postmenopausal (16) | 16 (84.2) | 0 | |
| Histologic tumor grade | |||
| 1 | 1 (5.3) | 1 (5.3) | 0.011 |
| 2 | 3 (15.7) | 0 | |
| 3 | 14 (73.6) | 0 | |
| Lymphovascular invasion | |||
| Present (18) | 18 (94.7) | 0 | 0.040 |
| Absent (1) | 0 | 1 (5.3) | |
| Lymph node status | |||
| Positive (17) | 17 (89.4) | 0 | 0.186 |
| Negative (2) | 1 (5.3) | 1 (5.3) | |
| Tumor size | |||
| T1, T2 (13) | 13 (68.4) | 0 | 0.138 |
| T3 (4) | 3 (15.8) | 1 (5.3) | |
| T4 (2) | 2 (10.5) | 0 | |
| Stage | |||
| 1, 2 (12) | 11 (57.9) | 1 (5.3) | 0.779 |
| 3 (7) | 7 (36.8) | 0 | |
| Ki67 | |||
| Positive (19) | 18 (94.7) | 1 (5.3) | |